HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]

[embedded content] Español Tick-borne diseases, such as Lyme disease, are on the rise in people and dogs. Reported cases in people in the U.S. increased from […]

Other Ways to Contact CDER Phone Numbers Main FDA for general inquiries: 1-888-INFO-FDA​ (1-888-463-6332​) Drug Information: 301-796-3400​ (8:00 AM – 4:30 PM Eastern Time) To submit a […]

From Supplier to Patient The graphic depicts how a drug moves through the supply chain. A drug starts with the active pharmaceutical ingredient supplier and on […]

Image By: Patrizia Cavazzoni, MD, Director, Center for Drug Evaluation and Research and Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research An estimated […]

FDA responds to potential drug shortages by taking actions to address their underlying causes and to enhance product availability. FDA determines how best to address each […]

On This Page Date: September 24 – 25, 2024 Day1: Tue, Sep 24 8:30 AM – 4:30 PM ET Day2: Wed, Sep 25 8:30 AM – […]

Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of […]

Disease Awareness and Prescription Drug Communications on Television CDER researchers conducted two experimental studies among adult asthma patients to determine how the similarity, proximity (how close […]